dbGaP Study Accession: phs003368
NIH Institute/Center: NIMHD
RADx Data Program: RADx-UP
Release Date: 03/04/2024
DOI: 10.60773/86j7-he45
Study Description: SCALE-UP II was a state-wide, pragmatic study conducted among 11 Community Health Center (CHC) systems and 38 clinics across Utah. These CHCs serve low socioeconomic status, racially/ethnically diverse, and rural/frontier populations. The long-term objective of SCALE-UP II was to increase the reach, uptake, and sustainability of COVID-19 testing among underserved populations. Through RADx-UP Phase I funding (SCALE-UP Utah), the team had established population health management (PHM) interventions that have been used since Jan 2021 to increase the uptake of COVID-19 testing and vaccination among CHC patients. Interventions were based on a PHM approach that uses widely available technology (i.e. cell phones and text messaging). SCALE-UP II built on SCALE-UP Utah PHM interventions and investigated novel interventions (i.e., Conversational Agents; Reactive Patient Navigation) that are tailored to address individuals' hesitancy factors and the interplay between vaccination and testing.
Updated Date: 03/04/2024
Principal Investigator: Fiol, Guilherme
Has Data Files: Yes
Study Domain: Vaccination Rate/Uptake; Virological Testing; Testing Rate/Uptake; Community Outreach Programs
Data Collection Method: Survey
Study Design: Observational
Multi-Center Study: TRUE
Study Sites: Association for Utah Community Health
Data Types: Questionnaires/Surveys
Study Start Date: 12/30/2021
Study End Date: 11/30/2022
Species: Human Data
Estimated Cohort Size: 40000
Study Population Focus: Rural Communities; Children; Adults; Older Adults or Elderly; Lower Socioeconomic Status (SES) Population; Racial and Ethnic Minorities; Underserved/Vulnerable Population
Acknowledgement Statement: This study was supported through funding, 1U01MD017421-01, for the National Institute on Minority Health and Health Disparities (NIMHD) as part of the RADx-UP program. We are sincerely grateful to our primary collaborators on this project, the Association for Utah Community Health, the Utah Department of Health, and our participating clinics. Additionally, we are grateful to our participants who made this study possible. Approved users should acknowledge the provision of data access by dbGaP for accession phs003368.v1.p1, and the NIH RADx Data Hub. Approved users should also acknowledge the specific version(s) of the dataset(s) obtained from the NIH RADx Data Hub.
Funding Opportunity Announcement (FOA) Number: RFA-OD-21-008
NIH Grant or Contract Number(s): 1U01MD017421-01
Consent/Data Use Limitations: General Research Use